Delivery Order SPE2DB24D3013-SPE2DB25FFRBB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) valued at $1,373.34. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, valued at $1,816.32 with a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,599.35, is for the delivery of Primaquine 26.3 mg tablets over a period ending on March 28, 2025. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,279.27, is for the delivery of Primaquine 26.3mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of the medication Primaquine 26.3 mg. The contract has a ceiling value of $1,888.30 and a completion date of July 2, 2025. The award date is July 1, 2025, and the contract is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $697.20 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 tablets of 26.3 mg primaquine. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corp, will perform the contract from its location in Conshohocken, Pennsylvania. The delivery order is associated with indefinite-delivery/indefinite-quantity medical and pharmaceutical prime vendor contracts held by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) with a contract value of $1,713.32. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- This federal contract award, valued at $2,680.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Primaquine 26.3 mg tablets, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,049.77 by the Defense Logistics Agency on September 23, 2025, for the delivery of Primaquine 26.3 mg tablets (100-count) with a completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFRBBDelivery Order
The Defense Logistics Agency awarded a $2,018.72 delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) with a completion date of September 29, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through this prime vendor arrangement, AmerisourceBergen provides essential pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide, with the DLA planning to establish additional regional contracts as part of the Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/26/25 |